Cita APA (7a ed.)

Kansal, A. R., Reifsnider, O. S., Brand, S. B., Hawkins, N., Coughlan, A., Li, S., . . . Caro, J. J. (2021). Economic evaluation of betibeglogene autotemcel (Beti-cel) gene addition therapy in transfusion-dependent β-thalassemia. Taylor & Francis Group.

Cita Chicago Style (17a ed.)

Kansal, Anuraag R., et al. Economic Evaluation of Betibeglogene Autotemcel (Beti-cel) Gene Addition Therapy in Transfusion-dependent β-thalassemia. Taylor & Francis Group, 2021.

Cita MLA (8a ed.)

Kansal, Anuraag R., et al. Economic Evaluation of Betibeglogene Autotemcel (Beti-cel) Gene Addition Therapy in Transfusion-dependent β-thalassemia. Taylor & Francis Group, 2021.